Immune development in HIV-exposed uninfected children born to HIV-infected women

Autor(es)

Miyamoto, Maristela ; Gouvea, Aida F. T. B. ; Ono, Erika ; Succi, Regina Celia M. ; Pahwa, Savita ; de Moraes-Pinto, Maria Isabel

• Tipo de documento: Artigo Científico
• Fonte: Revista do Instituto de Medicina Tropical de São Paulo; v. 59, 2017.
• Citações Web of Science: 5

Resumo

ABSTRACT Immunological and clinical findings suggestive of some immune dysfunction have been reported among HIV-exposed uninfected (HEU) children and adolescents. Whether these defects are persistent or transitory is still unknown. HEU pediatric population at birth, 12 months, 6-12 years were evaluated in comparison to healthy age-matched HIV-unexposed controls. Plasma levels of LPS, sCD14, cytokines, lymphocyte immunophenotyping and T-cell receptor excision circles (TREC) were assessed. HEU and controls had similar LPS levels, which remained low from birth to 6-12 years; for plasma sCD14, IL-2, IL-6, IL-7, IL-10, IL-12p70, IL-13, IL-17, IFN-γ, TNF-α, G-CSF, GM-CSF and MCP-1, which increased from birth to 12 months and then decreased at 6-12 years; and for TREC/106 PBMC at birth in HEU and controls. By contrast, plasma MIP-1β levels were lower in HEU than in controls (p=0.009) at 12 months, and IL-4 levels were higher in HEU than controls (p=0.04) at 6-12 years. Immune activation was higher in HEU at 12 months and at 6-12 years than controls based on frequencies of CD38+HLA-DR+CD8+T cells (p=0.05) and of CD38+HLA-DR+CD4+T cells (p=0.006). Resting memory and activated mature B cells increased from birth to 6-12 years in both groups. The development of the immune system in vertically HEU individuals is comparable to the general population in most parameters, but subtle or transient differences exist. Their role in influencing clinical incidences in HEU is unknown. (AU)

• Processo FAPESP: 10/09701-3 - Persistência da ativação imune de linfócitos de neonatos, crianças e adolescentes expostos e não infectados pelo vírus da imunodeficiência humana (HIV)
• Beneficiário: Maria Isabel de Moraes Pinto
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 10/09738-4 - Persistência da ativação imune de linfócitos de neonatos, crianças e adolescentes expostos e não infectados pelo vírus da imunodeficiência humana (hiv).
• Beneficiário: Maristela Miyamoto de Nóbrega
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado